Analysts Turn Bearish on Accenture and Lululemon
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Wall Street trimmed targets on several big names Friday. The moves signal growing caution across tech consulting, retail, and healthcare.
Accenture took the sharpest consensus hit. The average analyst target price fell to $197.65, down from $208.16. That is a cut of over $10 per share. The IT consulting giant carries a $78.6bn market cap. Bears outnumber bulls, with 15 sell ratings against 13 holds.
Lululemon also saw targets trimmed. The average dropped to $132.16 from $133.74. Two analysts now hold sell ratings on the stock. Short interest sits at 7.5% of free float — modest, but worth watching given the bearish consensus shift.
On the bullish side, Take-Two Interactive got an upgrade to its target. The average rose to $279.45. The gaming firm has 28 buy ratings against just one sell. With GTA VI still in focus, analysts remain firmly positive.
Eli Lilly also received a target bump to $1,218.72. Buyers dominate with 22 buy ratings. The pharma giant continues to ride demand for its weight-loss drugs.
Datadog picked up a new analyst recommendation. Its consensus stands at 43 buys, making it one of the most widely backed tech stocks on the Street.
Stocks in this article
How this article was generated
- Generated
- 20 Jun 2026, 12:20
- Prompt version
- v1.0
- Data sources
- Analyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.